TGFB1 and cancer: Furthermore, it was found that resistance to cancer therapy and metastasis shared many signaling pathways that confer metastasis-associated resistance, including chemokine receptor, Wnt/β-catenin, transforming growth factor-β (TGF-β) and receptor tyrosine kinase (RTK) signaling pathways [9].